Quick-reference chart (all vials at 10 mg/mL) Notice the pattern
As of April 2026, the following clinical realities must be noted: Limited Human Trials: While Phase 1/2 exploratory studies have investigated peptide safety and local administration (e.g., intra-articular for osteoarthritis), large-scale Randomized Controlled Trials (RCTs) confirming systemic efficacy in humans are absent (Dove Medical Press, 2025)
Changes from baseline in cardiovascular, metabolic, and inflammatory biomarkers among GLP-1 drug users were as follows: Triglycerides: -16.4 mg/dL LDL cholesterol: -7.3 mg/dL HbA1c: -0.3 percentage points CRP: -0.6 mg/dL ESR: -3.0 mm/hr These were all numerically greater than corresponding changes for non-users, but often the differences didn't reach statistical significance
These include ailments such as megaloblastic anaemia, peripheral neuropathy and other neurological problems that arise due to a lack of sufficient vitamin B12
Embracing a diet rich in protein not only supports short-term weight loss goals but also lays the foundation for sustainable lifestyle changes that promote lifelong health and vitality